Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
20.28
-0.88 (-4.16%)
At close: Dec 5, 2025, 4:00 PM EST
20.26
-0.02 (-0.10%)
After-hours: Dec 5, 2025, 5:01 PM EST
Neurogene Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | - | 0.93 | - | - | - |
| Cost of Revenue | 69.72 | 60.82 | 44.39 | 47.51 | 42.26 |
| Gross Profit | -69.72 | -59.89 | -44.39 | -47.51 | -42.26 |
| Selling, General & Admin | 27.59 | 22.61 | 11.19 | 9.01 | 8.27 |
| Operating Expenses | 27.59 | 22.61 | 11.19 | 9.01 | 8.27 |
| Operating Income | -97.31 | -82.51 | -55.58 | -56.52 | -50.53 |
| Interest Expense | -0.01 | -0.01 | -0.01 | -0 | - |
| Interest & Investment Income | 11.14 | 8.47 | 2.95 | 1.34 | 0.02 |
| Other Non Operating Income (Expenses) | 1.04 | -0.99 | -0.03 | -0.01 | - |
| EBT Excluding Unusual Items | -85.13 | -75.04 | -52.67 | -55.19 | -50.52 |
| Asset Writedown | - | -0.1 | - | - | - |
| Other Unusual Items | - | - | 16.36 | - | - |
| Pretax Income | -85.13 | -75.14 | -36.32 | -55.19 | -50.52 |
| Net Income | -85.13 | -75.14 | -36.32 | -55.19 | -50.52 |
| Preferred Dividends & Other Adjustments | - | - | -49.97 | - | - |
| Net Income to Common | -85.13 | -75.14 | 13.65 | -55.19 | -50.52 |
| Shares Outstanding (Basic) | 21 | 18 | 0 | 0 | 4 |
| Shares Outstanding (Diluted) | 21 | 18 | 5 | 0 | 4 |
| Shares Change (YoY) | 60.75% | 277.22% | 1080.37% | -90.26% | - |
| EPS (Basic) | -4.12 | -4.28 | 27.76 | -139.88 | -12.47 |
| EPS (Diluted) | -4.12 | -4.28 | 2.93 | -139.88 | -12.47 |
| Free Cash Flow | -78.41 | -71.41 | -51.74 | -55.05 | -64.77 |
| Free Cash Flow Per Share | -3.79 | -4.07 | -11.11 | -139.54 | -15.99 |
| Operating Margin | - | -8919.46% | - | - | - |
| Profit Margin | - | -8123.68% | - | - | - |
| Free Cash Flow Margin | - | -7720.11% | - | - | - |
| EBITDA | -94.21 | -79.26 | -52.29 | -53.32 | -49.59 |
| D&A For EBITDA | 3.1 | 3.25 | 3.3 | 3.2 | 0.95 |
| EBIT | -97.31 | -82.51 | -55.58 | -56.52 | -50.53 |
Source: S&P Capital IQ. Standard template.
Financial Sources.